Metronidazole
- Product NDC
- 0440-1796
- 11-digit product format
- 004401796
- Labeler code
- 0440
- Product ID
- 0440-1796_fd60fa16-9bd2-4337-b52f-bf71d6e14714
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metronidazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Liberty Pharmaceuticals, Inc.
- Application
- ANDA070033
- Marketing category
- ANDA
- Marketing start
- 1990-09-30
- Marketing end
- 0000-00-00
- Substance
- METRONIDAZOLE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0440-1796 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 0440-1796 | 0440-1796-14 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A070033-001 | METRONIDAZOLE | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 1984-12-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A070033-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A070033-001 | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | 1984-12-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A070033-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 53918705-d2fe-4c6b-9501-a619a8ad3991 | 2026-07-03 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 1a28dce0-07af-401a-a6ac-1c2ee559c668 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
| Metronidazole | METRONIDAZOLE | Redpharm Drug, inc. | f426cddc-8b70-c0a7-e053-2995a90a74e0 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | e1e7e127-e99e-80e9-1606-71261658b0c1 | 2024-11-04 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | e313c7d9-fb7b-4d0f-bccf-cc72ac5ef205 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
| Metronidazole | METRONIDAZOLE | Teva Pharmaceuticals USA, Inc. | 291a45f6-ed27-4dcc-8364-358d08623797 | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | 070033 ANDA070033 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55 | Product name | 5 | 20251024 |
| 7f6d14e0-4366-41bc-a4a9-b74c79a20e17 | Product name | 1 | 20250623 |
| e6d321b0-0e5e-7da6-f043-92b6a91f00a1 | Product name | 5 | 20250515 |
| e1aac33b-94ae-4ee9-905b-299f7263853b | Product name | 3 | 20250124 |
| 16642716-d28a-4f90-8dcb-3921cd8c8109 | Product name | 4 | 20240516 |
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| a5070875-62bb-61e1-fd46-8f7054197a40 | Product name | 8 | 20180215 |
| 0add4de9-d152-3375-3390-1123dddc5e3d | Product name | 1 | 20140508 |
| 33ca0fcc-1011-92dc-50a9-a383683eed1e | Product name | 1 | 20140508 |
| 53f39d9f-cd3f-04e1-c668-d4580719d57d | Product name | 1 | 20140508 |
| a804000f-b74f-0b5d-d17b-aa767c286ddb | Product name | 1 | 20140508 |
| a91ea265-6e02-c08f-93c8-686d54180529 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0440-1796-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8404-f424-e053-dadaa90a57ce | METRONIDAZOLE TABLETS USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0440-1796-14 | Metronidazole | 14 in 1 BOTTLE, PLASTIC | TABLET | 14 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0440-1796-14 | EA - Each | 0440-1796 | fac088f9-f45b-4e77-99e5-0cd803d407da | 1 | 2013-10-17 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METRONIDAZOLE | ACTIVE INGREDIENT | 140QMO216E | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| METRONIDAZOLE | ACTIVE MOIETY | 140QMO216E | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| HYDROGENATED COTTONSEED OIL | INACTIVE INGREDIENT | Z82Y2C65EA | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | METRONIDAZOLE TABLET [LIBERTY PHARMACEUTICALS, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | 5911e8f2-1b3a-4222-b997-d2a1c9a9f535 | 1 |
| 311681 | metroNIDAZOLE 500 MG Oral Tablet | PSN | 5911e8f2-1b3a-4222-b997-d2a1c9a9f535 | 1 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | 5911e8f2-1b3a-4222-b997-d2a1c9a9f535 | 1 |
| 311681 | metronidazole 500 MG Oral Tablet | SCD | 5911e8f2-1b3a-4222-b997-d2a1c9a9f535 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 0440-1796-14 | 00440179614 | 14 in 1 BOTTLE, PLASTIC | Historical |